PNU-282987 is a highly selective α7 nicotinic acetylcholine receptor (α7 nAChR) agonist with Ki of 27 nM. PNU-282987 has no detectable agonist activity and negligible antagonist activity at the neuromuscular junction form of the receptor (α1β1γδ), the predominant ganglionic nAChR (α3β4), and the α4β2 subtype. PNU-282987 is found to be a functional antagonist of the 5-HT3 receptor with IC50 of ~4.5 μM. PNU-282987 displays potent activity at both α7-5HT3 chimera and native α7 nAChR. PNU-282987 is shown to open native alpha7 nAChRs in cultured rat neurons in a concentration-dependent manner, which can be blocked by MLA. Consistently, PNU-282987 reverse an amphetamine-induced gating deficit in rats. PNU-282987 is inactive against a panel of 32 receptors at 1 μM, except 5-HT3 receptors with Ki of 930 nM. PNU-282987 enhances GABAergic synaptic activity when applied to hippocampal slices. Furthermore, PNU-282987 improves the inherent hippocampal gating deficit occurring in a subpopulation of anesthetized rats, and enhances amphetamine-induced hippocampal θ oscillation.Systemic administration of PNU-282987 significantly enhances the power (by 40%) of hippocampal theta oscillation induced by electrical stimulation of the brainstem reticular formation in anaesthetized rats, suggesting that precognitive actions of alpha7 nAChR agonists could be mediated, at least in part, by modulation of hippocampal oscillatory activity.
Bosn J Basic Med Sci. 2022 May 10.
The α7nAChR agonist PNU-282987 ameliorates sepsis-induced acute kidney injury via CD4+CD25+ regulatory T cells in rats
PNU-282987 purchased from AbMole
Bosn J Basic Med Sci. 2022 Oct 23;22(6):882-893.
The α7 nicotinic acetylcholine receptor agonist PNU-282987 ameliorates sepsis-induced acute kidney injury through CD4+CD25+ regulatory T cells in rats
PNU-282987 purchased from AbMole
| Molecular Weight | 301.21 |
| Formula | C14H17ClN2O.HCl |
| CAS Number | 123464-89-1 |
| Solubility (25°C) | DMSO: ≥ 30 mg/mL |
| Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
| Species | Mouse | Rat | Rabbit | Guinea pig | Hamster | Dog |
| Weight (kg) | 0.02 | 0.15 | 1.8 | 0.4 | 0.08 | 10 |
| Body Surface Area (m2) | 0.007 | 0.025 | 0.15 | 0.05 | 0.02 | 0.5 |
| Km factor | 3 | 6 | 12 | 8 | 5 | 20 |
| Animal A (mg/kg) = Animal B (mg/kg) multiplied by | Animal B Km |
| Animal A Km |
For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.
| Related AChR/AChE Products |
|---|
| Tacrine
Tacrine is a potent acetylcholinesterse (AChE) inhibitor (IC50=109 nM), also acting as a CYP1A2 substrate agent. |
| THRX-160209
THRX-160209 is a potent antagonist at the M(2) muscarinic acetylcholine (ACh) receptor subtype that was designed using a multivalent strategy, simultaneously targeting the orthosteric site and a nearby site known to bind allosteric ligands. |
| Catestatin
Catestatin is a 21-amino acid residue, cationic and hydrophobic peptide. |
| α-Conotoxin MII
α-Conotoxin MII (α-CTxMII), a 16-amino acid peptide from the venom of the marine snail Conus magus, potently blocks nicotinic acetylcholine receptors (nAChRs) composed of α3β2 subunits, with an IC50 of 0.5 nM. |
| COG 133 TFA
COG 133 TFA is a fragment of Apolipoprotein E (APOE) peptide. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
